Cargando…

Development and Validation of Two Self-Reported Tools for Insulin Resistance and Hypertension Risk Assessment in A European Cohort: The Feel4Diabetes-Study

Early identification of type 2 diabetes mellitus (T2DM) and hypertension (HTN) risk may improve prevention and promote public health. Implementation of self-reported scores for risk assessment provides an alternative cost-effective tool. The study aimed to develop and validate two easy-to-apply scre...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanellakis, Spyridon, Mavrogianni, Christina, Karatzi, Kalliopi, Lindstrom, Jaana, Cardon, Greet, Iotova, Violeta, Wikström, Katja, Shadid, Samyah, Moreno, Luis A., Tsochev, Kaloyan, Bíró, Éva, Dimova, Rumyana, Antal, Emese, Liatis, Stavros, Makrilakis, Konstantinos, Manios, Yannis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230581/
https://www.ncbi.nlm.nih.gov/pubmed/32235566
http://dx.doi.org/10.3390/nu12040960
_version_ 1783534987877810176
author Kanellakis, Spyridon
Mavrogianni, Christina
Karatzi, Kalliopi
Lindstrom, Jaana
Cardon, Greet
Iotova, Violeta
Wikström, Katja
Shadid, Samyah
Moreno, Luis A.
Tsochev, Kaloyan
Bíró, Éva
Dimova, Rumyana
Antal, Emese
Liatis, Stavros
Makrilakis, Konstantinos
Manios, Yannis
author_facet Kanellakis, Spyridon
Mavrogianni, Christina
Karatzi, Kalliopi
Lindstrom, Jaana
Cardon, Greet
Iotova, Violeta
Wikström, Katja
Shadid, Samyah
Moreno, Luis A.
Tsochev, Kaloyan
Bíró, Éva
Dimova, Rumyana
Antal, Emese
Liatis, Stavros
Makrilakis, Konstantinos
Manios, Yannis
author_sort Kanellakis, Spyridon
collection PubMed
description Early identification of type 2 diabetes mellitus (T2DM) and hypertension (HTN) risk may improve prevention and promote public health. Implementation of self-reported scores for risk assessment provides an alternative cost-effective tool. The study aimed to develop and validate two easy-to-apply screening tools identifying high-risk individuals for insulin resistance (IR) and HTN in a European cohort. Sociodemographic, lifestyle, anthropometric and clinical data obtained from 1581 and 1350 adults (baseline data from the Feel4Diabetes-study) were used for the European IR and the European HTN risk assessment index respectively. Body mass index, waist circumference, sex, age, breakfast consumption, alcohol, legumes and sugary drinks intake, physical activity and sedentary behavior were significantly correlated with Homeostatic Model Assessment of IR (HOMA-IR) and/or HTN and incorporated in the two models. For the IR index, the Area Under the Curve (AUC), sensitivity and specificity for identifying individuals above the 75th and 95th of HOMA-IR percentiles were 0.768 (95%CI: 0.721–0.815), 0.720 and 0.691 and 0.828 (95%CI: 0.766–0.890), 0.696 and 0.778 respectively. For the HTN index, the AUC, sensitivity and specificity were 0.778 (95%CI: 0.680–0.876), 0.667 and 0.797. The developed risk assessment tools are easy-to-apply, valid, and low-cost, identifying European adults at high risk for developing T2DM or having HTN.
format Online
Article
Text
id pubmed-7230581
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-72305812020-05-22 Development and Validation of Two Self-Reported Tools for Insulin Resistance and Hypertension Risk Assessment in A European Cohort: The Feel4Diabetes-Study Kanellakis, Spyridon Mavrogianni, Christina Karatzi, Kalliopi Lindstrom, Jaana Cardon, Greet Iotova, Violeta Wikström, Katja Shadid, Samyah Moreno, Luis A. Tsochev, Kaloyan Bíró, Éva Dimova, Rumyana Antal, Emese Liatis, Stavros Makrilakis, Konstantinos Manios, Yannis Nutrients Article Early identification of type 2 diabetes mellitus (T2DM) and hypertension (HTN) risk may improve prevention and promote public health. Implementation of self-reported scores for risk assessment provides an alternative cost-effective tool. The study aimed to develop and validate two easy-to-apply screening tools identifying high-risk individuals for insulin resistance (IR) and HTN in a European cohort. Sociodemographic, lifestyle, anthropometric and clinical data obtained from 1581 and 1350 adults (baseline data from the Feel4Diabetes-study) were used for the European IR and the European HTN risk assessment index respectively. Body mass index, waist circumference, sex, age, breakfast consumption, alcohol, legumes and sugary drinks intake, physical activity and sedentary behavior were significantly correlated with Homeostatic Model Assessment of IR (HOMA-IR) and/or HTN and incorporated in the two models. For the IR index, the Area Under the Curve (AUC), sensitivity and specificity for identifying individuals above the 75th and 95th of HOMA-IR percentiles were 0.768 (95%CI: 0.721–0.815), 0.720 and 0.691 and 0.828 (95%CI: 0.766–0.890), 0.696 and 0.778 respectively. For the HTN index, the AUC, sensitivity and specificity were 0.778 (95%CI: 0.680–0.876), 0.667 and 0.797. The developed risk assessment tools are easy-to-apply, valid, and low-cost, identifying European adults at high risk for developing T2DM or having HTN. MDPI 2020-03-30 /pmc/articles/PMC7230581/ /pubmed/32235566 http://dx.doi.org/10.3390/nu12040960 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kanellakis, Spyridon
Mavrogianni, Christina
Karatzi, Kalliopi
Lindstrom, Jaana
Cardon, Greet
Iotova, Violeta
Wikström, Katja
Shadid, Samyah
Moreno, Luis A.
Tsochev, Kaloyan
Bíró, Éva
Dimova, Rumyana
Antal, Emese
Liatis, Stavros
Makrilakis, Konstantinos
Manios, Yannis
Development and Validation of Two Self-Reported Tools for Insulin Resistance and Hypertension Risk Assessment in A European Cohort: The Feel4Diabetes-Study
title Development and Validation of Two Self-Reported Tools for Insulin Resistance and Hypertension Risk Assessment in A European Cohort: The Feel4Diabetes-Study
title_full Development and Validation of Two Self-Reported Tools for Insulin Resistance and Hypertension Risk Assessment in A European Cohort: The Feel4Diabetes-Study
title_fullStr Development and Validation of Two Self-Reported Tools for Insulin Resistance and Hypertension Risk Assessment in A European Cohort: The Feel4Diabetes-Study
title_full_unstemmed Development and Validation of Two Self-Reported Tools for Insulin Resistance and Hypertension Risk Assessment in A European Cohort: The Feel4Diabetes-Study
title_short Development and Validation of Two Self-Reported Tools for Insulin Resistance and Hypertension Risk Assessment in A European Cohort: The Feel4Diabetes-Study
title_sort development and validation of two self-reported tools for insulin resistance and hypertension risk assessment in a european cohort: the feel4diabetes-study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230581/
https://www.ncbi.nlm.nih.gov/pubmed/32235566
http://dx.doi.org/10.3390/nu12040960
work_keys_str_mv AT kanellakisspyridon developmentandvalidationoftwoselfreportedtoolsforinsulinresistanceandhypertensionriskassessmentinaeuropeancohortthefeel4diabetesstudy
AT mavrogiannichristina developmentandvalidationoftwoselfreportedtoolsforinsulinresistanceandhypertensionriskassessmentinaeuropeancohortthefeel4diabetesstudy
AT karatzikalliopi developmentandvalidationoftwoselfreportedtoolsforinsulinresistanceandhypertensionriskassessmentinaeuropeancohortthefeel4diabetesstudy
AT lindstromjaana developmentandvalidationoftwoselfreportedtoolsforinsulinresistanceandhypertensionriskassessmentinaeuropeancohortthefeel4diabetesstudy
AT cardongreet developmentandvalidationoftwoselfreportedtoolsforinsulinresistanceandhypertensionriskassessmentinaeuropeancohortthefeel4diabetesstudy
AT iotovavioleta developmentandvalidationoftwoselfreportedtoolsforinsulinresistanceandhypertensionriskassessmentinaeuropeancohortthefeel4diabetesstudy
AT wikstromkatja developmentandvalidationoftwoselfreportedtoolsforinsulinresistanceandhypertensionriskassessmentinaeuropeancohortthefeel4diabetesstudy
AT shadidsamyah developmentandvalidationoftwoselfreportedtoolsforinsulinresistanceandhypertensionriskassessmentinaeuropeancohortthefeel4diabetesstudy
AT morenoluisa developmentandvalidationoftwoselfreportedtoolsforinsulinresistanceandhypertensionriskassessmentinaeuropeancohortthefeel4diabetesstudy
AT tsochevkaloyan developmentandvalidationoftwoselfreportedtoolsforinsulinresistanceandhypertensionriskassessmentinaeuropeancohortthefeel4diabetesstudy
AT biroeva developmentandvalidationoftwoselfreportedtoolsforinsulinresistanceandhypertensionriskassessmentinaeuropeancohortthefeel4diabetesstudy
AT dimovarumyana developmentandvalidationoftwoselfreportedtoolsforinsulinresistanceandhypertensionriskassessmentinaeuropeancohortthefeel4diabetesstudy
AT antalemese developmentandvalidationoftwoselfreportedtoolsforinsulinresistanceandhypertensionriskassessmentinaeuropeancohortthefeel4diabetesstudy
AT liatisstavros developmentandvalidationoftwoselfreportedtoolsforinsulinresistanceandhypertensionriskassessmentinaeuropeancohortthefeel4diabetesstudy
AT makrilakiskonstantinos developmentandvalidationoftwoselfreportedtoolsforinsulinresistanceandhypertensionriskassessmentinaeuropeancohortthefeel4diabetesstudy
AT maniosyannis developmentandvalidationoftwoselfreportedtoolsforinsulinresistanceandhypertensionriskassessmentinaeuropeancohortthefeel4diabetesstudy
AT developmentandvalidationoftwoselfreportedtoolsforinsulinresistanceandhypertensionriskassessmentinaeuropeancohortthefeel4diabetesstudy